Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2,2-디클로로-1,1,1-트리플루오르에탄
2,2-다이클로로-1,1,1-트라이플루오로에테인 · 2,2-디클로로-1,1,1-트리플루오르에탄 · 1,1,1-트라이플루오로-2,2-다이클로로에테인 · 1,1,1-트라이플루오로다이클로로에테인 · 1,1-다이클로로-2,2,2,-트라이플루오로에테인 · 1,1-다이클로로-2,2,2-트라이플루오로에테인 · 다이클로로(트라이플루오로메틸)메테인 · 다이클로로트라이플루오로에테인

식별자 및 물리적 특성
| CAS No. | 306-83-2 |
|---|---|
| 분자식 | C2HCl2F3 |
| 평균 분자량 | 152.93 g/mol |
| 단동위원소 질량 | 151.94074005 g/mol |
| SMILES | FC(F)(F)C(Cl)Cl |
| InChIKey | OHMHBGPWCHTMQE-UHFFFAOYSA-N |
| PubChem CID | 9385 |
| EC No. | 206-190-3 |
| DTXSID | DTXSID7020712 |
| 현지명 | 2,2-디클로로-1,1,1-트리플루오르에탄 |
화학 및 물리적 성질
| XLogP | 2.7 |
|---|---|
| 극성 표면적 | 0 |
| 수소 결합 공여자 수 | 0 |
| 수소 결합 수용자 수 | 3 |
| 회전 가능 결합 수 | 0 |
| 무거운 원자 수 | 7 |
| 형식 전하 | 0 |
| 복잡도 | 56.4 |
| 물질 분류 | Volatile Organic Compound (VOC) |
| PFAS | PFAS -> PFAS identified in REACH Regulation EC No. 1272/2008 |
| Solvents | Solvents -> Chlorofluorocarbons |
| SpringerMaterials Properties | Schoenflies notation |
| 냄새 | Slight ethereal odor |
| 밀도 | 1.4638 g/cu cm at 25 °CRelative density (water = 1): 1.51.4638 @25 °C1,475 g/cm3 |
| Color/Form | Clear, colorless liquid |
| 용해도 | In water, 2100 mg/L at 25 °CSolubility in water, g/100ml at 25 °C: 0.21 |
| 끓는 점 | 27.82 °C28 °C27.82 °C @760 [mm Hg]27.6°C |
| Decomposition | Decomposes on heating. This produces phosgene, hydrogen fluoride and hydrogen chloride.When heated to decomposition it emits very toxic fumes of /hydrogen chloride and hydrogen fluoride/.Under certain conditions, /chlorofluorocarbon/ vapors may decompose on contact with flames or hot surfaces, creating the potential hazard of inhalation of toxic decomposition products. /Chlorofluorocarbon/The appearance of toxic decomposition products serves as warning of the occurrence of thermal decompositon and detection of a sharp acrid odor warns of the presence of these products. /Fluorocarbons/ |
| 녹는점 | -107 °C-107°C |
| 증기 밀도 | Relative vapor density (air = 1): 6.4 |
| 증기압 | 93.456kPa at 25.62℃ |
| 굴절률 | 1.3290 |
| 인화점 | 9℃ |
| 저장 조건 | 2-8°C |
| 물리적 상태 | 액체 |
| 용해도 | 2.1g/L at 25℃ |
| 비열 | Cp(gas): 0.67 J/(g·K), at 25℃ |
| 헨리 상수 | 2.3×10-4 mol/(m3Pa) at 25℃, Kutsuna (2013) |
| LogP(분배 계수) | 2.17 at 20℃ |
| NIST | Ethane, 2,2-dichloro-1,1,1-trifluoro-(306-83-2) |
| EPA | HCFC-123 (306-83-2) |
| ECETOC JACC REPORT | 1,1-Dichloro-2,2,2-trifluoroethane (306-83-2) |
화학적 성질
1,1-Dichloro-2,2,2-trifluoroethane has a light ethereal odor with poor warning properties.
안전 및 규제
| GHS 분류 | This chemical does not meet GHS hazard criteria for 2.1% (3 of 144) of reports.WarningH336 (32.6%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposureNarcotic effects]P260, P261, P264, P270, P271, P304+P340, P308+P316, P319, P403+P233, P405, P501, and P502 (click each P-code to see the statement)Aggregated GHS information provided per 144 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Danger |
|---|---|
| 규제 정보 | Chemical: Ethane, 2,2-dichloro-1,1,1-trifluoro-Ethane, 2,2-dichloro-1,1,1-trifluoro- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Ethane, 2,2-dichloro-1,1,1-trifluoro- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Status: Active Update: 31-03-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/120602,2-dichloro-1,1,1-trifluoroethane: Does not have an individual approval but may be used under an appropriate group standardThe New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.) |
| 기타 안전 정보 | PEC / SN / Other assessments - 2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123): Health |
| 화재 위험 | Not combustible. |
| 유해성 요약 | See CHLOROFLUOROCARBONS.An eye irritantCan cause liver injury, narcosis, and cardiac arrhythmias[ICSC] Effects in high-dose animal studies include anesthesia[MSDSonline] Several clusters of occupational hepatitis have been reported, e.g., after HCFC-123 leaked in an air-conditioning system in a crane cabin and after HCFC-123 was used as a degreaser[AIHA] |
| FDA 요건 | The Food and Drug Administration (FDA), after consultation with the Environmental Protection Agency (EPA), is amending FDA's regulation on the use of ozone-depleting substances (ODSs) in selfpressurized containers to remove the essential-use designations for flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil used in oral pressurized metered-dose inhalers (MDIs). The Clean Air Act requires FDA, in consultation with the EPA, to determine whether an FDA-regulated product that releases an ODS is an essential use of the ODS. FDA has concluded that there are no substantial technical barriers to formulating flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil as products that do not release ODSs, and therefore they will no longer be essential uses of ODSs as of the effective dates of this rule. MDIs for these active moieties containing an ODS may not be marketed after the relevant effective date. DATES: Removal of Part 2.125(e)(2)(iii) and 2.125(e)(4)(vii) is effective June 14, 2010. Removal of Part 2.125(e)(1)(v) and 2.125(e)(4)(iv) is effective December 31, 2010. Removal of Part 2.125(e)(1)(iii) is effective June 30, 2011. Removal of 2.125(e)(2)(iv) and Part 2.125(e)(4)(viii) is effective December 31, 2013. /Ozone-Depleting Substances/ |
용도
용도
HCFC 123 is an interim replacement for the CFCs and is scheduled for a production phase-out during the 2020s. Its main application is as a substitute for CFC 11 in centrifugal chillers used for air conditioning of large buildings. It is also used in smaller air-conditioning units, and may have applications in foam blowing, and firefighting and as a chemical intermediate.
일반 설명
Colorless nonflammable gas. Nearly odorless.